Cole Jo
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
Papers in
-
- Schizophrenia research and treatment 8
- Electroconvulsive Therapy Studies 6
- Attention Deficit Hyperactivity Disorder 4
-
- Treatment of Major Depression 6
- Co-authors
- Klerman Gl (2 shared papers)G. Gárdos (9 shared papers)David W. Marby (1 shared paper)Ladislav Volicer (1 shared paper)John Levine (1 shared paper)S Schniebolk (2 shared papers)Lipman Rs (1 shared paper)Brian A. Lieberman (1 shared paper)
- Journals
- Journal of Clinical Psychopharmacology (1 paper)British Journal of Clinical Pharmacology (1 paper)Brunel University Research Archive (BURA) (Brunel University London) (1 paper)Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (32 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Cole Jo
34 papers receiving 476 citations
Peers
Comparison fields: 5 of 86
- Biological Psychiatry 47
- Psychiatry and Mental health 273
- Toxicology 35
- Pharmacology 172
- Cellular and Molecular Neuroscience 143
Countries citing papers authored by Cole Jo
This map shows the geographic impact of Cole Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cole Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cole Jo more than expected).
Fields of papers citing papers by Cole Jo
This network shows the impact of papers produced by Cole Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cole Jo. The network helps show where Cole Jo may publish in the future.
Co-authors
The 14 scholars most cited alongside Cole Jo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical pharmacology of imipramine and related antidepressant compounds. | 1967 | 224 |
| 2 | Response to clozapine in chronic psychotic patients. | 1989 | 46 |
| 3 | Evaluation of pyrovalerone in chronically fatigued volunteers. | 1971 | 38 |
| 4 | A dose-response study of propranolol in chronic schizophrenics. | 1973 | 32 |
| 5 | EFFECTS OF ANESTHESIA ON METABOLISM AND CELLULAR FUNCTIONS. A WORKSHOP HELD UNDER THE COMMITTEE ON ANESTHESIA OF THE NATIONAL ACADEMY OF SCIENCES--NATIONAL RESEARCH COUNCIL. | 1965 | 26 |
| 6 | The prognosis of tardive dyskinesia. | 1983 | 21 |
| 7 | New directions in antidepressant therapy: a review of sertraline, a unique serotonin reuptake inhibitor. | 1992 | 15 |
| 8 | Indications for high dose chlorpromazine therapy in chronic schizophrenia. | 1970 | 13 |
| 9 | The therapeutic role of methylphenidate in senile organic brain syndrome. | 1980 | 13 |
| 10 | 1981 | 12 | |
| 11 | Antidepressant adverse drug reactions. | 1991 | 12 |
| 12 | Toward a biochemical classification of depressive disorders IV: Pretreatment urinary MHPG levels as predictors of antidepressant response to imipramine. | 1980 | 11 |
| 13 | A phenomenological approach to the classification of schizophrenic disorders. | 1963 | 10 |
| 14 | Pilot study of cyproheptadine (Periactin) in tardive dyskinesia [proceedings]. | 1978 | 9 |
| 15 | Patient report of significant life situation events (methodological implications for outpatient drug evaluation). | 1965 | 9 |
| 16 | Five-year follow-up study of tardive dyskinesia. | 1985 | 8 |
| 17 | High and low dose thiothixene treatment in chronic schizophrenia. | 1974 | 7 |
| 18 | Possible pathophysiological mechanisms in subtypes of unipolar depressive disorders based on differences in urinary MHPG levels [proceedings]. | 1981 | 7 |
| 19 | Haloperidol in the treatment of psychoneurotic anxious outpatients. | 1976 | 6 |
| 20 | A survey of diazepam patients. | 1986 | 6 |
About Cole Jo
Cole Jo is a scholar working on Psychiatry and Mental health, Pharmacology, Pediatrics, Perinatology and Child Health, Clinical Psychology and Molecular Biology, having authored 36 papers that have together received 576 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (8 papers), Electroconvulsive Therapy Studies (6 papers), Treatment of Major Depression (6 papers), Attention Deficit Hyperactivity Disorder (4 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Mental Health and Psychiatry (2 papers), Tryptophan and brain disorders (2 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). The work is most often cited by research in Biological Psychiatry (47 citations), Psychiatry and Mental health (273 citations), Toxicology (35 citations), Pharmacology (172 citations) and Cellular and Molecular Neuroscience (143 citations). Cole Jo has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Klerman Gl, G. Gárdos, David W. Marby, Ladislav Volicer, John Levine, S Schniebolk, Lipman Rs, Brian A. Lieberman, David Haskell and Toshihiko Maruta. Their work appears in journals such as Journal of Clinical Psychopharmacology, British Journal of Clinical Pharmacology, Brunel University Research Archive (BURA) (Brunel University London), Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.